Lv1
50 积分 2025-02-15 加入
In vivo CTL immunity can be elicited by OVA-linker-beta2m fusion protein
14小时前
求助中
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
16天前
已完结
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
1个月前
已完结
Membrane‐coated nanoparticles for direct recognition by T cells
1个月前
已完结
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
3个月前
已完结
Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies
4个月前
已完结
皖公网安备34019202002308
